US Market Access Director — Povetacicept IgAN Launch

Vertex Pharmaceuticals; Boston (MA); Hybrid; USD 232,000 - 348,000; Full time

Job summary

Vertex Pharmaceuticals in Boston seeks a Senior Director, US Market Access Strategy to lead payer strategy, pricing, contracting, and evidence development for povetacicept (POVE) in IgAN and future indications.

You will guide a cross‑functional team, align launch readiness across US Market Access, and build a compelling payer value proposition to ensure timely patient access and favorable reimbursement.

Qualifications

• Bachelor's degree in a relevant field required; advanced degree preferred.
• Experience leading payer contracting and access strategies for launch products.
• Strong understanding of US payer landscape, policy, and regulatory environment.

Responsibilities

• Lead POVE pricing and contracting strategies for current and future indications.
• Oversee development of the POVE value proposition with HEOR.
• Spearhead US Market Access launch readiness across functional areas.
• Address barriers to access using contracting and pricing analytics.
• Develop payer-channel market access strategies for patient access.
• Lead a team of 3–4 direct reports and drive KPI-based initiatives.
• Lead the annual long-range planning and market access brand planning.
• Develop promotional resources and reimbursement pull-through for field teams.
• Manage external vendors to deliver insights within budget.

Skills

Payer contracting

Pricing strategy

Market access

Contracting experience

Cross-functional leadership

US healthcare system knowledge

Communication skills

Launch experience

Team leadership

Vendors management

Education

Bachelor's degree

Advanced degree preferred

Job description

Vertex Pharmaceuticals in Boston seeks a Senior Director, US Market Access Strategy to lead payer strategy, pricing, contracting, and evidence development for povetacicept (POVE) in IgAN and future indications.

You will guide a cross‑functional team, align launch readiness across US Market Access, and build a compelling payer value proposition to ensure timely patient access and favorable reimbursement.